SCHEMBL17323745

SCHEMBL17323745

CCc1cccc(Nc2ccc(N)c3c2C(=O)c2ccccc2C3=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY4 P51582 10/20 0.64
▸ FGR P09769 1/20 0.47
▸ PIM1 P11309 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ CSNK1A1 P48729 1/20 0.47
▸ CSNK1D P48730 1/20 0.47
▸ DYRK1A Q13627 1/20 0.47
▸ HIPK2 Q9H2X6 1/20 0.47
▸ CSNK1G1 Q9HCP0 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ MMP14 P50281 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ P2RY12 Q9H244 6/20 0.45
▸ P2RY2 P41231 5/20 0.45
▸ P2RY6 Q15077 2/20 0.45
▸ GNG2 P59768 2/20 0.45
▸ GNB1 P62873 2/20 0.45
▸ PTGS1 P23219 1/20 0.43
▸ PRKCA P17252 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14613068 0.89 P2RY4 (0.51) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL14582107 0.88 P2RY4 (0.53) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL10940967 0.87 P2RY4 (0.50) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL17320715 0.87 P2RY4 (0.50) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL11540883 0.86 P2RY4 (0.61) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL10613450 0.84 P2RY4 (0.54) P2RY4KMT2APTGS1ALDH1A1HPGD
SCHEMBL5718104 0.83 P2RY4 (0.62) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL10415363 0.83 GNG2 (0.62) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL30918998 0.81 ADORA2A (0.63) P2RY4FGRPIM1MAOAADORA2A
SCHEMBL169365 0.81 ADORA2A (0.63) P2RY4FGRPIM1MAOAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150353485-A1 SECURITY ELEMENT HAVING VOLUME HOLOGRAM AND PRINTED FEATURE COVESTRO DEUTSCHLAND AG (DE) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353485-A1 SECURITY ELEMENT HAVING VOLUME HOLOGRAM AND PRINTED FEATURE SHH, ABL1, MKI67 P2RY4 1969/4885FGR 438/4885PIM1 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback